These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30501637)

  • 1. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model.
    Dekens DW; Naudé PJW; Keijser JN; Boerema AS; De Deyn PP; Eisel ULM
    J Neuroinflammation; 2018 Nov; 15(1):330. PubMed ID: 30501637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
    Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
    J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Activation of Astrocytes does not Affect Amyloid Plaque Load in an Animal Model of Alzheimer's Disease.
    Wang D; Zhang X; Wang M; Zhou D; Pan H; Shu Q; Sun B
    Neurosci Bull; 2018 Dec; 34(6):912-920. PubMed ID: 30032411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D
    J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.
    Daschil N; Obermair GJ; Flucher BE; Stefanova N; Hutter-Paier B; Windisch M; Humpel C; Marksteiner J
    J Alzheimers Dis; 2013; 37(2):439-51. PubMed ID: 23948887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body vibration ameliorates glial pathological changes in the hippocampus of hAPP transgenic mice, but does not affect plaque load.
    Oroszi T; Geerts E; Rajadhyaksha R; Nyakas C; van Heuvelen MJG; van der Zee EA
    Behav Brain Funct; 2023 Mar; 19(1):5. PubMed ID: 36941713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
    CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's disease.
    Löffler T; Flunkert S; Havas D; Schweinzer C; Uger M; Windisch M; Steyrer E; Hutter-Paier B
    J Neuroinflammation; 2014 May; 11():84. PubMed ID: 24886182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer's Disease.
    Ameen-Ali KE; Simpson JE; Wharton SB; Heath PR; Sharp PS; Brezzo G; Berwick J
    J Alzheimers Dis; 2019; 68(2):609-624. PubMed ID: 30814360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment.
    McAllister C; Long J; Bowers A; Walker A; Cao P; Honda S; Harada N; Staufenbiel M; Shen Y; Li R
    J Neurosci; 2010 May; 30(21):7326-34. PubMed ID: 20505099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression.
    Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G
    J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.